Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans.
about
Year in review 2009: Critical Care--cardiac arrest, trauma and disastersSerum S100B levels after meningioma surgery: A comparison of two laboratory assays.Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 °C and 36 °C.Combining NSE and S100B with clinical examination findings to predict survival after resuscitation from cardiac arrest.Continuous evaluation of neurological prognosis after cardiac arrest.Protein analysis of atrial fibrosis via label-free proteomics in chronic atrial fibrillation patients with mitral valve disease.MicroRNAs: new biomarkers and therapeutic targets after cardiac arrest?Predictive value of S100-B and copeptin for outcomes following seizure: the BISTRO International Cohort Study.Early postoperative serum S100 beta levels predict ongoing brain damage after meningioma surgery: a prospective observational studySerum neuron-specific enolase as early predictor of outcome after in-hospital cardiac arrest: a cohort study.Pharmacological postconditioning with sevoflurane after cardiopulmonary resuscitation reduces myocardial dysfunction.The Need to Develop Standardized Protocols for the Timing of Extracorporeal Membrane Oxygenation Initiation among Adult Patients in Cardiac Arrest: A Case Study.Early prediction of individual outcome following cardiopulmonary resuscitation: systematic review.Brain Damage and Motor Cortex Impairment in Chronic Obstructive Pulmonary Disease: Implication of Nonrapid Eye Movement Sleep Desaturation.Association between cerebrospinal fluid S100B protein and neuronal damage in patients with central nervous system infections.Neuron specific enolase: a promising therapeutic target in acute spinal cord injury.Carbon Monoxide Improves Neurologic Outcomes by Mitochondrial Biogenesis after Global Cerebral Ischemia Induced by Cardiac Arrest in Rats.Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational studyA new objective method for CT triage after minor head injury--serum S100B.S-100B and neuron-specific enolase as predictors of neurological outcome in patients after cardiac arrest and return of spontaneous circulation: a systematic review.Echocardiography for patients undergoing extracorporeal cardiopulmonary resuscitation: a primer for intensive care physicians.Post-anoxic vegetative state: imaging and prognostic perspectives.Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury.Biomarkers as predictors of outcome after cardiac arrest.Novel approaches for prevention of stroke related to transcatheter aortic valve implantation.Monitoring biomarkers of cellular injury and death in acute brain injury.Cardiovascular causes of emergency neurology presenting to an ICU.Global cerebral ischemia due to circulatory arrest: insights into cellular pathophysiology and diagnostic modalities.Serum Trace Element Profiles, Prolactin, and Cortisol in Transient Ischemic Attack Patients.Incremental Value of Circulating MiR-122-5p to Predict Outcome after Out of Hospital Cardiac Arrest.Utility of serum concentration of protein S100 at admission to the medical intensive care unit in prediction of permanent neurological injury.Comparison of Cerebral Metabolism between Pig Ventricular Fibrillation and Asphyxial Cardiac Arrest ModelsPostmortem stability of S100B in the aqueous humor of northern fur seals (Callorhinus ursinus).Correlation of systemic protein S100β levels with postoperative indicators of neurological damage in supratentorial meningioma surgery.The effect of granulocyte colony-stimulating factor administration on carbon monoxide neurotoxicity in rats.Novel surrogate markers for acute brain damage: cerebrospinal fluid levels corrrelate with severity of ischemic neurodegeneration in the rat.S-100B protein as a serum marker of secondary neurological complications in neurocritical care patients.Cerebral and extracerebral release of protein S100B in cardiac surgical patients.Serum S100B levels in patients with cerebral and extracerebral infectious disease.Neurochemical monitoring using intracerebral microdialysis during systemic haemorrhage.
P2860
Q30396874-E1BB243D-06E5-447B-B707-410972E49282Q33370648-47E21D75-64F8-4C70-83A6-C48D9D0711E1Q33814315-19183A1C-0AA0-4A6F-A93B-AF5228C56836Q33865045-27FF79DB-C2E0-44A3-85DA-D2005D3F55CDQ34352550-6D38B068-FCB0-48FE-92B0-DB939A259218Q34672752-5A61EE3E-89EF-4510-8619-15132E59292BQ35071551-C18572FE-EBAE-4E62-B65A-1EE2E995DAB3Q35301002-E62B3062-7711-473C-905E-F6C7928AAC1BQ35544698-9B187E27-ECF6-43F1-8EA7-38C3152BC658Q35544724-00B02552-8862-4164-ACA1-0BCC562EC6BAQ35908259-DB0431E2-499F-4647-810F-E61397AF2641Q36019161-D1C78B18-9657-4B67-B1B2-8FF6D496FAA2Q36270242-52446042-E42B-4366-999A-2B0C6103CCFEQ36461058-7BB5C6B2-35D1-4529-ABEF-0E998170BEB3Q36793165-E8F85980-2944-4934-AE31-9C34C07CA528Q36892833-C939A871-90EA-4126-8B5B-4DEC68525DF8Q37148564-13B9C0A4-5D2F-4FF4-B08C-6CF4BFF90454Q37210155-4778A420-77F0-4472-ACB5-CA6371BE185CQ37387101-7F1152ED-A251-4CE6-BE8C-3DDD5C80AD6DQ37558758-8A15F8DA-B81D-4626-AC61-867BB1561AF5Q37620804-E76C8F8A-BCD8-441C-97E3-A0761E9BA9A4Q37892674-B9D1A9C6-AD2D-4142-BCA0-880B6C19FFA7Q37905540-2584261E-53F9-496E-8E7A-924EECC82B4FQ38066961-CD6E59FF-E465-4B24-AF5D-3163B8770C7DQ38153782-C6934E37-C69C-4BA9-A241-3C8FCBC06F26Q38248158-3F2215B1-963A-47C9-B4D8-44E128764936Q38614547-676E5590-C189-4EAD-98FF-900346FA8052Q39023204-99524ABA-1C93-40C4-A746-DF494D76A838Q40211551-3C08E81F-02BD-46FE-ABFF-A2F7D6E34058Q41430273-343D4B17-7258-4949-A8D4-A027A1AFBBB4Q41858000-C0488C24-C077-4939-A43D-19A43BC85ABBQ42538028-F7A43BEA-68CD-4444-B1E0-DA268B2F37DCQ45769122-3A35A57F-660C-4201-B7A6-55254DE8BCE9Q45793211-85B531EC-3007-43FB-8779-ACF04CC8DE73Q46441301-9844E1FB-5DC5-4E1A-8BF6-579A978F5F94Q46497516-489FAF90-7E34-4A6A-9EB0-03A660560E15Q47338898-B16EA567-43DC-4B4C-9392-4E80BEB4B30AQ47947463-FA10690E-AB77-4B1C-BDCA-F538923E20B1Q48001550-30C34B3F-0D14-429E-81A3-1ADCA246B75DQ48125329-F7300C55-0AAB-401C-BCFC-BD2093802269
P2860
Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Astroglial protein S-100 is an ...... fter cardiac arrest in humans.
@en
Astroglial protein S-100 is an ...... fter cardiac arrest in humans.
@nl
type
label
Astroglial protein S-100 is an ...... fter cardiac arrest in humans.
@en
Astroglial protein S-100 is an ...... fter cardiac arrest in humans.
@nl
prefLabel
Astroglial protein S-100 is an ...... fter cardiac arrest in humans.
@en
Astroglial protein S-100 is an ...... fter cardiac arrest in humans.
@nl
P2093
P1433
P1476
Astroglial protein S-100 is an ...... fter cardiac arrest in humans.
@en
P2093
Böttiger BW
P304
P356
10.1161/01.CIR.103.22.2694
P407
P577
2001-06-01T00:00:00Z